发明名称 |
UREA DERIVATIVE |
摘要 |
<p>A urea derivative having excellent DGAT inhibitory activity or a pharmacologically acceptable salt thereof. The urea derivative is represented by the general formula (I) (II) (III) (XXXIX) (XL) [wherein R<SUP>1</SUP> is, e.g., C<SUB>6-10 </SUB>aryl optionally substituted independently by one to five groups selected from substituent groups (a); R<SUP>2</SUP> is, e.g., C<SUB>6-10</SUB> aryl optionally substituted independently by one to five groups selected from substituent groups (a); E is, e.g., a group having the formula (II) or (III) (wherein R<SUP>3</SUP> is hydrogen, etc.; R<SUP>4</SUP> and R<SUP>5</SUP> are the same or different and each is hydrogen, etc.; X and U are the same or different and each is CH, etc.; and m and n are the same or different and each is 1, etc.); and A is -NH-C(=O)-, etc.].</p> |
申请公布号 |
WO2006004200(A1) |
申请公布日期 |
2006.01.12 |
申请号 |
WO2005JP12635 |
申请日期 |
2005.07.01 |
申请人 |
SANKYO COMPANY, LIMITED;KURATA, HITOSHI;UTO, YOSHIKAZU;FUJIBAYASHI, YUKO;KOHAMA, TAKAFUMI;TANIMOTO, TATSUO;KARASAWA, HIROSHI |
发明人 |
KURATA, HITOSHI;UTO, YOSHIKAZU;FUJIBAYASHI, YUKO;KOHAMA, TAKAFUMI;TANIMOTO, TATSUO;KARASAWA, HIROSHI |
分类号 |
(IPC1-7):C07D211/62;A61P15/08;A61P13/12;A61P11/00;A61P9/12;A61P9/10;A61P9/00;A61P3/10;A61P3/06;A61P3/04;A61P1/16;A61K31/551;A61K31/496;A61K31/495;A61K31/472;A61K31/451;A61K31/444;A61K31/443;C07D417/12;C07D405/12;C07D401/14;C07D401/12;C07D295/20;C07D295/18;C07D295/12;C07D243/08;C07D241/04;C07D217/06;C07D213/76;C07D213/75;C07D211/60;A61P43/00;A61P27/12;A61P27/02;A61P25/02;A61P21/00;A61P19/06;A61P19/02 |
主分类号 |
(IPC1-7):C07D211/62 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|